Tumor necrosis factor-α inhibitor-related autoimmune disorders

Th2 IL-4/IL-13 dual blockade with Dupilumab is linked to some Emergent Th17 type Diseases including seronegative arthritis, enthesitis/enthesopathy, but not humoral autoimmune diseases

(2022) Charlie Bridgewood et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update

(2022) Josef S Smolen et al.   ANNALS OF THE RHEUMATIC DISEASES

Cutaneous vasculitis associated with molecular tergeted therapies: systematic review of the literature

(2022) Tumay Ak et al.   CLINICAL RHEUMATOLOGY

Adalimumab-induced sarcoidosis-like reaction involving oral cavity in rheumatoid arthritis: a case-based review

(2021) Carla Isabelly Rodrigues-Fernandes et al.   CLINICAL RHEUMATOLOGY

Aseptic meningitis in rheumatoid arthritis after anti-TNF administration: a case-based literature review

(2021) Reşit Yıldırım et al.   RHEUMATOLOGY INTERNATIONAL

Anti-TNF-α-induced lupus syndrome

(2021) Cristiana Sieiro Santos et al.   ZEITSCHRIFT FUR RHEUMATOLOGIE

Case Report: Systemic Small-Vessel Vasculitis in an Adolescent With Active Ulcerative Colitis

(2021) Marleen Bouhuys et al.   Frontiers in Pediatrics

Pyoderma gangrenosum induced by adalimumab in a seropositive rheumatoid arthritis patient: a paradoxical effect of adalimumab?

(2021) Yvonne Tan et al.   RHEUMATOLOGY

Demyelinating Events Following Initiation of Anti-TNFα Therapy in the British Society for Rheumatology Biologics Registry in Rheumatoid Arthritis

(2021) Thomas R.P. Taylor et al.   Neurology-Neuroimmunology & Neuroinflammation

Systemic sarcoidosis reactions as a result of tumour necrosis factor‐alpha treatment for patients with psoriasis

(2021) A. P. Bewley et al.   CLINICAL AND EXPERIMENTAL DERMATOLOGY

Drug-induced sarcoidosis-like reactions

(2021) Jelle Miedema et al.   CURRENT OPINION IN PULMONARY MEDICINE

Expression of microRNA‐21 and TIMP‐3 in paradoxical psoriasiform reactions during treatment with antitumor necrosis factor agents

(2021) Raquel Navarro et al.   JOURNAL OF CUTANEOUS PATHOLOGY

Late-onset Etanercept-associated Ocular Sarcoidosis with Profound Vision Loss

(2021) Murtaza Saifee et al.   OCULAR IMMUNOLOGY AND INFLAMMATION

Paradoxical psoriasis in pediatric patients: A systematic review

(2021) Benoit M. Cyrenne et al.   PEDIATRIC DERMATOLOGY

IgA Vasculitis in Patients with Inflammatory Bowel Disease: new insights into the role of TNF-α blockers

(2021) Camille Rasmussen et al.   RHEUMATOLOGY

Effect of introducing biologics to patients with rheumatoid arthritis on the risk of venous thromboembolism: a nationwide cohort study

(2021) Chao-Ping Chen et al.   Scientific Reports

Anti-TNF-Related Leukocytoclastic Vasculitis in Ulcerative Colitis: A Case Report

(2021) Valentina Giorgio et al.   International Journal of Environmental Research and Public Health

Use of anti-TNF-α therapy in Crohn's disease is associated with increased incidence of multiple sclerosis

(2021) Jagannadha Avasarala et al.   Multiple Sclerosis and Related Disorders

Dupilumab-induced enthesoarthritis and refractory atopic dermatitis successfully treated with baricitinib

(2021) Ludovico De Stefano et al.   RHEUMATOLOGY

Vasculitis induced by biological agents used in rheumatology practice: A systematic review

(2021) Camila da Silva Cendon Duran et al.   Archives of Rheumatology

Established rheumatoid arthritis. The pathogenic aspects

(2020) Serena Bugatti et al.   BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY

Paradoxical Hidradenitis Suppurativa in Patients Receiving TNF-α Inhibitors: Case Series, Systematic Review, and Case Meta-Analysis

(2020) Luis Salvador-Rodriguez et al.   DERMATOLOGY

Anti-TNF rechallenge after infliximab induced lupus in Crohn’s disease: A Practical Teaching Case

(2020) Moshe Loebenstein et al.   GASTROENTEROLOGY

Histologic comparison of tumor necrosis factor-α inhibitor–induced psoriasis and psoriasis vulgaris

(2020) Jeffrey Zhu Hu et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Risk of neuroinflammatory events in arthritis patients treated with tumour necrosis factor alpha inhibitors: a collaborative population-based cohort study from Denmark and Sweden

(2020) Tine Iskov Kopp et al.   ANNALS OF THE RHEUMATIC DISEASES

Association Between Tumor Necrosis Factor Inhibitor Exposure and Inflammatory Central Nervous System Events

(2020) Amy Kunchok et al.   JAMA Neurology

Paradoxical Skin Reaction to Certolizumab, an Overlap of Pyoderma Gangrenosum and Psoriasis in a Young Woman Treated for Ankylosing Spondylitis: Case Report with Literature Review

(2020) Anna Gawdzik et al.   Dermatology and Therapy

Family history of psoriasis, psychological stressors, and tobacco use are associated with the development of tumor necrosis factor-α inhibitor-induced psoriasis: A case-control study

(2020) Jason Ya et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Spondyloarthritis-Associated IgA Nephropathy

(2020) Nicolas Champtiaux et al.   Kidney International Reports

Tumor necrosis factors‐α inhibition‐induced paradoxical psoriasis: A case series and literature review

(2020) Ni Lian et al.   Dermatologic Therapy

Systematic review and meta-analysis of dermatological reactions in patients with inflammatory bowel disease treated with anti-tumour necrosis factor therapy

(2020) Gaurav B. Nigam et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Drug-induced Bullous Pemphigoid and Lupus Erythematosus Occurring under Anti-TNF-α and IL-6 Therapy in a Patient with Rheumatoid Arthritis

(2020) Noritada Yoshikawa et al.   INTERNAL MEDICINE

Paradoxical Psoriasis Induced by Anti-TNFα Treatment: Evaluation of Disease-Specific Clinical and Genetic Markers

(2020) Agostino Bucalo et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Systematic Review: Monoclonal Antibody-Induced Subacute Cutaneous Lupus Erythematosus

(2020) Chrissy Bolton et al.   DRUGS IN R&D

Drug-induced IgA vasculitis in children and adults: Revisiting drug causality using a dual pharmacovigilance-based approach

(2020) Camille Rasmussen et al.   AUTOIMMUNITY REVIEWS

Paradoxical eruptions to targeted therapies in dermatology: A systematic review and analysis

(2020) Michael J. Murphy et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Intermittent Purpura Development Associated with Leukocytoclastic Vasculitis Induced by Infliximab for Crohn's Disease

(2020) Kenichi Kishimoto et al.   INTERNAL MEDICINE

Differential roles of TNFα-TNFR1 and TNFα-TNFR2 in the differentiation and function of CD4+Foxp3+ induced Treg cells in vitro and in vivo periphery in autoimmune diseases

(2019) Sujuan Yang et al.   Cell Death & Disease

Drug-induced systemic lupus: revisiting the ever-changing spectrum of the disease using the WHO pharmacovigilance database

(2019) Laurent Arnaud et al.   ANNALS OF THE RHEUMATIC DISEASES

2019 update of the EULAR recommendations for the management of systemic lupus erythematosus

(2019) Antonis Fanouriakis et al.   ANNALS OF THE RHEUMATIC DISEASES

Increased risk of developing Crohn’s disease or ulcerative colitis in 17 018 patients while under treatment with anti-TNFα agents, particularly etanercept, for autoimmune diseases other than inflammatory bowel disease

(2019) Joshua Korzenik et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

TNFR1 and TNFR2 in the Control of the Life and Death Balance of Macrophages

(2019) Harald Wajant et al.   Frontiers in Cell and Developmental Biology

Severe Attack of Henoch-Schönlein Purpura With Neurological Involvement During Adalimumab Treatment for Crohn’s Disease

(2019) Morgane Condamina et al.   Journal of Crohns & Colitis

Iatrogenic demyelinating disorders: New insights, new culprits

(2019) Hesham Abboud   Multiple Sclerosis Journal

TNF activity and T cells

(2018) Amit K. Mehta et al.   CYTOKINE

Drug-induced aseptic meningitis: a mini-review

(2018) Melissa Yelehe-Okouma et al.   FUNDAMENTAL & CLINICAL PHARMACOLOGY

Clinical management of Anti-TNF-alpha-induced psoriasis or psoriasiform lesions in inflammatory bowel disease patients: a systematic review

(2018) Francisco J. Melo et al.   INTERNATIONAL JOURNAL OF DERMATOLOGY

The Prevalence of Renal Impairment in Patients with Spondyloarthritis: Results from the International ASAS-COMOSPA Study

(2018) Marion Couderc et al.   JOURNAL OF RHEUMATOLOGY

TNF blockade induces a dysregulated type I interferon response without autoimmunity in paradoxical psoriasis

(2018) Curdin Conrad et al.   Nature Communications

Role of TNF–TNF Receptor 2 Signal in Regulatory T Cells and Its Therapeutic Implications

(2018) Sujuan Yang et al.   Frontiers in Immunology

Harmful Effects and Potential Benefits of Anti-Tumor Necrosis Factor (TNF)-α on the Liver

(2018) Loris Lopetuso et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Tumor Necrosis Factor Inhibitors and Risk of Peripheral Neuropathy in Patients with Rheumatic Diseases

(2018) Mahyar Etminan et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Psoriasis: Classical vs. Paradoxical. The Yin-Yang of TNF and Type I Interferon

(2018) Alessio Mylonas et al.   Frontiers in Immunology

Autoimmune diseases induced by biological agents. A review of 12,731 cases (BIOGEAS Registry)

(2017) Marta Pérez-De-Lis et al.   Expert Opinion On Drug Safety

Enfermedad inflamatoria intestinal como efecto paradójico del tratamiento con anti-TNF-α

(2017) Ainara Iriarte et al.   Gastroenterologia y Hepatologia

Low Doses of Etanercept Can Be Effective to Maintain Remission in Psoriatic Arthritis Patients

(2017) Renato de Stefano et al.   JCR-JOURNAL OF CLINICAL RHEUMATOLOGY

Cutaneous side-effects of biologics in immune-mediated disorders: A histopathological perspective

(2017) Farah Succaria et al.   JOURNAL OF DERMATOLOGY

Antitumor Necrosis Factor-α Therapy Associated with Inflammatory Bowel Disease: Three Cases and a Systematic Literature Review

(2017) Amir Bieber et al.   JOURNAL OF RHEUMATOLOGY

Severe Extraarticular Manifestations in a Community-based Cohort of Patients with Rheumatoid Arthritis: Risk Factors and Incidence in Relation to Treatment with Tumor Necrosis Factor Inhibitors

(2017) Lisa Theander et al.   JOURNAL OF RHEUMATOLOGY

Tumor necrosis factor-α inhibitor-induced psoriasis: Systematic review of clinical features, histopathological findings, and management experience

(2017) Gabrielle Brown et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Nodulosis reumatoidea pulmonar durante el tratamiento con fármacos anti-TNF

(2017) Pablo Antonio Zurita Prada et al.   MEDICINA CLINICA

Pyoderma gangrenosum and pyogenic arthritis presenting as severe sepsis in a rheumatoid arthritis patient treated with golimumab

(2017) Anastasia Skalkou et al.   RHEUMATOLOGY INTERNATIONAL

Três casos de miosite induzida pelo anti‐TNF e revisão da literatura

(2017) Orhan Zengin et al.   Revista Brasileira De Reumatologia

Update of EULAR recommendations for the treatment of systemic sclerosis

(2016) Otylia Kowal-Bielecka et al.   ANNALS OF THE RHEUMATIC DISEASES

Inflammatory Bowel Disease Provoked by Etanercept: Report of 443 Possible Cases Combined from an IBD Referral Center and the FDA

(2016) Aoibhlinn O’Toole et al.   DIGESTIVE DISEASES AND SCIENCES

Multiple sclerosis and inflammatory bowel diseases: a systematic review and meta-analysis

(2016) Maria Kosmidou et al.   JOURNAL OF NEUROLOGY

Immunogenicity and Lupus-Like Autoantibody Production Can Be Linked to Each Other along With Type I Interferon Production in Patients with Rheumatoid Arthritis Treated With Infliximab: A Retrospective Study of a Single Center Cohort

(2016) Yuki Ishikawa et al.   PLoS One

Anti-tumour necrosis factor treatment increases circulating T helper type 17 cells similarly in different types of inflammatory arthritis

(2015) D. N. Hull et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Acute Kidney Injury due to Renal Sarcoidosis during Etanercept Therapy: A Case Report and Literature Review

(2015) Mitsuhiro Akiyama et al.   INTERNAL MEDICINE

Paradoxical Expansion of Th1 and Th17 Lymphocytes in Rheumatoid Arthritis Following Infliximab Treatment: a Possible Explanation for a Lack of Clinical Response

(2015) Rossella Talotta et al.   JOURNAL OF CLINICAL IMMUNOLOGY

Transmembrane TNF–TNFR2 Impairs Th17 Differentiation by PromotingIl2Expression

(2015) Patrick G. Miller et al.   JOURNAL OF IMMUNOLOGY

Extraarticular Manifestations of Rheumatoid Arthritis in Patients under Anti-tumor Necrosis Factor-  Treatment

(2015) C. BACHMEYER et al.   JOURNAL OF RHEUMATOLOGY

Nodules in patients with rheumatoid arthritis and methotrexate treatment

(2015) Tadashi Nakamura et al.   Modern Rheumatology

Autoimmune hepatitis and anti-tumor necrosis factor alpha therapy: A single center report of 8 cases

(2015) Susana Rodrigues   WORLD JOURNAL OF GASTROENTEROLOGY

Acute ocular myositis occurring under etanercept for rheumatoid arthritis

(2014) Marion Couderc et al.   JOINT BONE SPINE

Extraarticular Manifestations of Rheumatoid Arthritis Develop in Patients Receiving Anti-Tumor Necrosis Factor-  Treatment: A Retrospective Chart Review from a UK Center

(2014) A. F. Negoescu et al.   JOURNAL OF RHEUMATOLOGY

Neurological adverse events in patients receiving anti-TNF therapy: a prospective imaging and electrophysiological study

(2014) Evripidis Kaltsonoudis et al.   ARTHRITIS RESEARCH & THERAPY

Treatment Comparison in Rheumatoid Arthritis: Head-to-Head Trials and Innovative Study Designs

(2014) Ennio Giulio Favalli et al.   Biomed Research International

Golimumab May Induce Exacerbation of Inflammatory Bowel Disease When It Is Used for the Treatment of Ankylosing Spondylitis

(2013) Muhammad Z. Bawany et al.   AMERICAN JOURNAL OF THERAPEUTICS

Drug-induced lupus and autoimmune hepatitis secondary to infliximab for psoriasis

(2013) Lucy J Dang et al.   AUSTRALASIAN JOURNAL OF DERMATOLOGY

Modulating the co-stimulatory signal for T cell activation in rheumatoid arthritis: Could it be the first step of the treatment?

(2013) Roberto Caporali et al.   AUTOIMMUNITY REVIEWS

Adalimumab-associated antiphospholipid syndrome: a case report and review of the literature

(2013) Iman Hemmati et al.   CLINICAL RHEUMATOLOGY

A case of infliximab-induced lupus in a patient with ankylosing spondylitis: is it safe switch to another anti-TNF-α agent?

(2013) Tânia Santiago et al.   CLINICAL RHEUMATOLOGY

Subacute lupus erythematosus during treatment with golimumab for seronegative rheumatoid arthritis

(2013) AMG Brunasso et al.   LUPUS

Immunogenicity of anti-TNF biologic therapies for rheumatoid arthritis

(2013) Pauline A. van Schouwenburg et al.   Nature Reviews Rheumatology

Pattern of demyelination occurring during anti-TNF-α therapy: a French national survey

(2013) Raphaèle Seror et al.   RHEUMATOLOGY

Incomplete response of inflammatory arthritis to TNFα blockade is associated with the Th17 pathway

(2012) Saba Alzabin et al.   ANNALS OF THE RHEUMATIC DISEASES

Drug induced autoimmune hepatitis and TNF-α blocking agents: Is there a real relationship?

(2012) Cumali Efe   AUTOIMMUNITY REVIEWS

Biologics-induced autoimmune diseases

(2012) Roberto Perez-Alvarez et al.   CURRENT OPINION IN RHEUMATOLOGY

Anti-TNF-Alpha Induced Psoriasiform Eruptions with Severe Scalp Involvement and Alopecia: Report of Five Cases and Review of the Literature

(2012) F. Osório et al.   DERMATOLOGY

Levels of Circulating Th17 Cells and Regulatory T Cells in Ankylosing Spondylitis Patients with an Inadequate Response to Anti−TNF-α Therapy

(2012) Li Xueyi et al.   JOURNAL OF CLINICAL IMMUNOLOGY

Autoimmune hepatitis following treatment with infliximab for inflammatory bowel disease

(2012) Chiara van Casteren-Messidoro et al.   Journal of Crohns & Colitis

Anti-tumor necrosis factor-α induced systemic lupus erythematosus in a patient with metastatic Crohn's disease—what is the role of anti-TNF antibody?

(2012) Klaudia Farkas et al.   Journal of Crohns & Colitis

Infliximab-Induced Psoriasis and Psoriasiform Skin Lesions in Pediatric Crohn Disease and a Potential Association With IL-23 Receptor Polymorphisms

(2012) Mary E. Sherlock et al.   JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION

Lupus-Like Syndrome Attributable to Anti—Tumor Necrosis Factor α Therapy in 14 Patients During an 8-Year Period at Mayo Clinic

(2012) David A. Wetter et al.   MAYO CLINIC PROCEEDINGS

Vasculitis Associated With Tumor Necrosis Factor-α Inhibitors

(2012) Olayemi Sokumbi et al.   MAYO CLINIC PROCEEDINGS

Regression von peripheren und pulmonalen Rheumaknoten unter Rituximab-Therapie

(2012) M.G. Braun et al.   ZEITSCHRIFT FUR RHEUMATOLOGIE

Venous thrombotic events are not increased in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register

(2011) R. Davies et al.   ANNALS OF THE RHEUMATIC DISEASES

TNF alpha antagonist-induced lupus-like syndrome: report and review of the literature with implications for treatment with alternative TNF alpha antagonists

(2011) Victoria L. Williams et al.   INTERNATIONAL JOURNAL OF DERMATOLOGY

Development of inflammatory bowel disease during anti-TNF-α therapy for inflammatory rheumatic disease. A nationwide series

(2011) Éric Toussirot et al.   JOINT BONE SPINE

Monoclonal antibody therapy-associated neurological disorders

(2011) Xavier Bosch et al.   Nature Reviews Neurology

The IL23R R381Q Gene Variant Protects against Immune-Mediated Diseases by Impairing IL-23-Induced Th17 Effector Response in Humans

(2011) Paola Di Meglio et al.   PLoS One

Drug-induced lupus in anti-TNF-alpha therapy and its treatment with rituximab

(2011) Juan C. Diaz et al.   RHEUMATOLOGY INTERNATIONAL

New Onset of Uveitis During Anti-Tumor Necrosis Factor Treatment for Rheumatic Diseases

(2011) Daniel Wendling et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Interstitial Lung Disease Induced or Exacerbated by TNF-Targeted Therapies: Analysis of 122 Cases

(2011) Roberto Perez-Alvarez et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Increasing levels of circulating Th17 cells and interleukin-17 in rheumatoid arthritis patients with an inadequate response to anti-TNF-α therapy

(2011) Der-Yuan Chen et al.   ARTHRITIS RESEARCH & THERAPY

Tumor Necrosis Factor Inhibitor–Associated Dermatomyositis

(2010) Rachel Klein et al.   ARCHIVES OF DERMATOLOGY

Tumor necrosis factor α blockade exacerbates murine psoriasis-like disease by enhancing Th17 function and decreasing expansion of Treg cells

(2010) Hak-Ling Ma et al.   ARTHRITIS AND RHEUMATISM

Etanercept-induced anti-Jo-1-antibody-positive polymyositis in a patient with rheumatoid arthritis: a case report and review of the literature

(2010) Yuki Ishikawa et al.   CLINICAL RHEUMATOLOGY

Dermatomyositis During Adalimumab Therapy for Rheumatoid Arthritis

(2010) A. M. G. BRUNASSO et al.   JOURNAL OF RHEUMATOLOGY

BSR and BHPR rheumatoid arthritis guidelines on safety of anti-TNF therapies

(2010) T. Ding et al.   RHEUMATOLOGY

Transmembrane TNF- : structure, function and interaction with anti-TNF agents

(2010) T. Horiuchi et al.   RHEUMATOLOGY

Occurrence of inflammatory bowel disease in four patients with juvenile idiopathic arthritis receiving etanercept or infliximab

(2010) M Tarkiainen et al.   SCANDINAVIAN JOURNAL OF RHEUMATOLOGY

Regulation of IFN response gene activity during infliximab treatment in rheumatoid arthritis is associated with clinical response to treatment

(2010) Lisa GM van Baarsen et al.   ARTHRITIS RESEARCH & THERAPY

Demyelinating events in rheumatoid arthritis after drug exposures

(2009) S. Bernatsky et al.   ANNALS OF THE RHEUMATIC DISEASES

Cytokine imbalance with increased production of interferon-α in psoriasiform eruptions associated with antitumour necrosis factor-α treatments

(2009) J. Seneschal et al.   BRITISH JOURNAL OF DERMATOLOGY

Accelerated Pathological and Clinical Nephritis in Systemic Lupus Erythematosus-Prone New Zealand Mixed 2328 Mice Doubly Deficient in TNF Receptor 1 and TNF Receptor 2 via a Th17-Associated Pathway

(2009) N. Jacob et al.   JOURNAL OF IMMUNOLOGY

Is the development of drug-related lupus a contraindication for switching from one TNF alpha inhibitor to another?

(2009) L Kocharla et al.   LUPUS

Recurrent pneumothorax associated with pulmonary nodules after leflunomide therapy in rheumatoid arthritis: a case report and review of the literature

(2009) Sun-Hee Kim et al.   RHEUMATOLOGY INTERNATIONAL

Anti-TNF-alpha-induced anti-phospholipid syndrome manifested as necrotizing vasculitis

(2009) E Vereckei et al.   SCANDINAVIAN JOURNAL OF RHEUMATOLOGY

Blockade of tumor necrosis factor in collagen-induced arthritis reveals a novel immunoregulatory pathway for Th1 and Th17 cells

(2008) Clare A. Notley et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Management of accelerated pulmonary nodulosis following etanercept therapy in a patient with rheumatoid arthritis

(2008) P. Watson et al.   RHEUMATOLOGY

Focus on adverse events of tumour necrosis factor   blockade in juvenile idiopathic arthritis in an open monocentric long-term prospective study of 163 patients

(2007) V Gerloni et al.   ANNALS OF THE RHEUMATIC DISEASES

Infliximab-induced lupus-like syndrome associated with autoimmune hepatitis

(2007) M. Marques et al.   INFLAMMATORY BOWEL DISEASES

Tumor necrosis factor antagonist mechanisms of action: A comprehensive review

(2007) Daniel Tracey et al.   PHARMACOLOGY & THERAPEUTICS

Drug-Induced Lupus due to Anti-Tumor Necrosis Factor α Agents

(2007) Michelle F. Costa et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM